Boston Partners’s Veracyte VCYT Stock Holding History

Boston Partners’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$30.4M	Buy	+661,382	New	+$31.9M	0.03%	327

Other funds holding VCYT

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Boston Partners's VCYT Position: Q3 2026 in Review

Boston Partners opened a new position in Veracyte (VCYT) in Q3 2026: 661,382 shares worth $30.4M. The stake represents 0.03% of the portfolio and ranks #327 among its holdings.

201 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

Boston Partners held 661,382 shares of Veracyte worth $30.4M as of Q3 2026.
Veracyte was a new Boston Partners position in Q3 2026.
Veracyte made up 0.03% of Boston Partners's portfolio in Q3 2026, its #327 holding.
201 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Boston Partners's 13F filing for Q3 2026, filed 10 Nov 2026.